Should antidiabetic medicines be considered to reduce cardiometabolic risk in patients with serious mental illness?

"Competing interests David Castle has received grant monies for research from Servier and Boehringer Ingelheim, and travel support and honoraria for talks and consultancy from Servier and Seqirus. He is a founder and holds a 50% intellectual property share of the Optimal Health Program, and is part owner of Clarity Health Care. He does not knowingly have stocks or shares in any pharmaceutical company."

"The Being Equally Well project has been partially supported by grant funding from the Australian Government Department of Health and Aged Care to the Mitchell Institute at Victoria University for the Australian Health Policy Collaboration, a network of chronic disease and population health academics, clinicians, experts, and advocates who have participated in this project. This supplement was financially supported by the Mitchell Institute, Victoria University, and by grant funding from the Australian Government Department of Health and Aged Care for the Australian Health Policy Collaboration."